Cognitive behavioral therapy for obsessive-compulsive disorder: An update

Current Psychiatry Reports

Volumn 7, Issue 4, 2005, Pages 268-273

  Huppert, Jonathan D ^a   Franklin, Martin E ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIPRAMINE; PLACEBO;

ADOLESCENT; BEHAVIOR THERAPY; CHILD; CHILD BEHAVIOR; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITIVE THERAPY; GROUPS BY AGE; HUMAN; INTERVIEW; OBSESSIVE COMPULSIVE DISORDER; OUTCOMES RESEARCH; PRESCRIPTION; PROBABILITY; PSYCHOTHERAPY; RATING SCALE; REVIEW; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 24944509683     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-005-0080-x     Document Type: Review

References (54)

1. Meyer V: Modification of expectations in cases with obsessional rituals. Behav Res Ther 1966, 4:273-280.
2. Marks IM, Hodgson R, Rachman S: Treatment of chronic obsessive-compulsive neurosis by in-vivo exposure: A two-year follow-up and issues in treatment. Br J Psychiatry 1975, 127:349-364.
3. Kozak MJ, Foa EB: Mastery of Obsessive-Compulsive Disorder: A Cognitive-Behavioral Approach (Therapist Guide). San Antonio, TX: Psychological Corporation/ Oxford University Press: 1997.
4. Rabavilas AD, Boulougouris JC, Perissaki C: Therapist qualities related to outcome with exposure in vivo in neurotic patients. J Behav Ther Exp Psychiatry 1979, 10:293-294.
5. Foa EB, Steketee G, Turner RM, Fischer SC: Effects of imaginal exposure to feared disasters in obsessive-compulsive checkers. Behav Res Ther 1980, 18:449-455.
6. Grayson JB, Foa EB, Steketee GS: Exposure in vivo of obsessive-compulsives under distracting and attention-focusing conditions: Replication and extension. Behav Res Ther 1986, 24:475-479.
7. Foa EB, Steketee G, Milby JB: Differential effects of exposure and response prevention in obsessive-compulsive washers. J Consult Clin Psychol 1980, 48:71-79.
8. Marks IM, Lelliott PT, Basoglu M, Noshirvani H: Clomipramine, self-exposure and therapist-aided exposure for obsessive-compulsive rituals. Br J Psychiatry 1988, 152:522-534.
9. Marks IM: Clomipramine and exposure for obsessive-compulsive rituals: I: Br J Psychiatry 1980, 136:1-25.
10. Cottraux J, Mollard E, Bouvard M, Marks I: A controlled study of fluvoxamine and exposure in obsessive-compulsive disorder. Int Clin Psychopharmacol 1990, 5:17-30.
11. van Balkom AJLM, de Haan E, van Oppen P, et al.: Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compulsive disorder. J Nerv Ment Dis 1998, 186:492-499.
12. Fals-Stewart W, Marks AP, Schafer J: A comparison of behavioral group therapy and individual behavior therapy in treating obsessive-compulsive disorder. J Nerv Ment Dis 1993, 181:189-193.
13. McLean PL, Whittal ML, Thordarson DS, et al.: Cognitive versus behavior therapy in the group treatment of obsessive-compulsive disorder. J Consult Clin Psychol 2001, 69:205-214.
14. Salkovskis PM: Obsessional-compulsive problems: A cognitive-behavioural analysis. Behav Res Ther 1985, 23:571-583.
15. Franklin ME, Abramowitz JS, Kozak MJ, et al.: Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: Randomized compared with nonrandomized samples. J Consult Clin Psychol 2000, 68:594-602.
16. Rothbaum BO, Shahar F: Behavioral treatment of obsessive-compulsive disorder in a naturalistic setting. Cogn Behav Pract 2000, 7:262-270.
17. Warren R, Thomas JC: Cognitive-behavior therapy of obsessive-compulsive disorder in private practice: An effectiveness study. J Anxiety Disord 2001, 15:277-285.
18. Friedman S, Smith LC, Halpern B, et al.: Obsessive-compulsive disorder in a multi-ethnic urban outpatient clinic: Initial presentation and treatment outcome with exposure and ritual prevention. Behav Ther 2003, 34:397-410.
19. Kobak KA, Greist JH, Jefferson JW, Katzelnick DJ: Behavioral versus pharmacological treatments of obsessive compulsive disorder. A meta-analysis. Outcomes Manage 1998, 136:205-216.
20. Abramowitz JS: Variants of exposure and response prevention in the treatment of obsessive-compulsive disorder. A meta-analysis. Behav Ther 1996, 27:583-600.
21. Abramowitz JS, Foa EB, Franklin ME: Exposure and ritual prevention for obsessive-compulsive disorder: Effects of intensive versus twice-weekly sessions. J Consult Clin Psychol 2003, 71:394-398.
22. Whittal, ML, Thordarson DS, McLean PD: Treatment of obsessive-compulsive disorder: Cognitive behavior therapy vs. exposure and response prevention. Behav Res Ther, In press.
23. Lang AJ, Craske MG, Bjork RA: Implications of a new theory of disuse for the treatment of emotional disorders. Clin Psychol Sci Pract 1999, 6:80-94.
24. Mataix-Cols D, do Rosario-Campos MC, Leckman JF: A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry 2005, 162:228-238.
25. McKay D, Abramowitz JS, Calamari JE, et al.: A critical evaluation of obsessive-compulsive disorder subtypes: Symptoms versus mechanisms. Clin Psychol Rev 2004, 24:283-313.
26. Mataix-Cols D, Marks IM, Greist JH, et al.: Obsessive-compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: Results from a controlled trial. Psychother Psychosom 2002, 71:255-262.
27. Abramowitz JS, Franklin ME, Schwartz SA, Furr JM: Symptom presentation and outcome of cognitive-behavioral therapy for obsessive-compulsive disorder. J Consult Clin Psychol 2003, 71:1049-1057.
28. Steketee G, Frost R: Compulsive hoarding: Current status of the research. Clin Psychol Rev 2003, 23:905-927.
29. Wu KD, Watson D: Hoarding and its relation to obsessive-compulsive disorder. Behav Res Ther, In press.
30. Grisham JR, Brown TA, Liverant GL, Campbell-Sills L: The distinctiveness of compulsive hoarding from obsessive-compulsive disorder. J Anxiety Disord, In press.
31. Cottraux J, Note I, Yao SN, et al.: A randomized controlled trial of cognitive therapy versus intensive behavior therapy in obsessive compulsive disorder. Psychother Psychosom 2001, 70:288-297.
32. Abramowitz JS, Franklin ME, Foa EB: Empirical status of cognitive-behavioral therapy for obsessive-compulsive disorder. A meta-analytic review. Romanian J Cogn Behav Psychother 2002, 2:89-104.
33. Wampold BE: The Great Psychotherapy Debate. Hillsdale, NJ: Lawrence Erlbaum: 2001.
34. Vogel PA, Stiles TC, Götestam KG: Adding cognitive therapy elements to exposure therapy for obsessive compulsive disorder: A controlled study. Behav Cogn Psychother 2004, 32:275-290.
35. Salkovskis PM: The future of psychological treatments for anxiety. Paper Presented at the European Association for Behavioural & Cognitive Therapies Annual Meeting. Manchester, UK; September 2004.
36. Abramowitz JS, Whiteside SP, Deacon BJ: The effectiveness of treatment for pediatric obsessive-compulsive disorder: A meta-analysis. Behav Ther 2005, 36:55-64.
37. Barrett P, Healy-Farrell L, March J: Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: A controlled trial. Journal of the American Academy of Child & Adolescent Psychiatry 2004, 43:46-62.
38. de Haan E, Hoogduin KA, Buitelaar J, Keijsers G: Behavior therapy versus clomipramine for the treatment of obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 1998, 37:1022-1029.
39. Pediatric OCD Treatment Study Team: Cognitive-behavioral therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: The Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA 2004, 292:1969-1976.
40. Piacentini J: Controlled comparison of CBT and relaxation training for childhood OCD. Paper presented at American Psychological Association Annual Meeting. Honolulu, HI; July, 2004.
41. Silverman W, Kurtines W, Ginsburg G, et al.: Contingency management, self-control, and education support in the treatment of childhood phobic disorders: A randomized clinical trial. J Consult Clin Psychology 1999, 67:675-687.
42. Valderhaug R, Gotestam KG, Larsson B, Piacentini JC: An open clinical trial of cognitive behaviour therapy for childhood obsessive-compulsive disorder in regular outpatient clinics. Paper presented at the SOGN Centre Conference on Pediatric Anxiety Disorders in Children and Adolescents. Oslo, Norway; May, 2004.
43. Foa EB, Liebowitz MR, Kozak MJ, et al.: Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry 2005, 162:151-161.
44. Simpson HB, Liebowitz MR, Foa EB, et al.: Post-treatment effects of exposure therapy and domipramine in obsessive-compulsive disorder. Depress Anxiety 2004, 19:225-233.
45. Hohagen F, Winkelmann G, Rasche-Räuchle H, et al.: Combination of behaviour therapy with fluvoxamine in comparison with behaviour therapy and placebo: Results of a multicentre study. Br J Psychiatry 1998, 173:71-78.
46. Franklin ME, Simpson HB: Combined treatment of obsessive compulsive disorder: Research findings and clinical applications. J Cogn Psychother, In press.
47. Cottraux J, Mollard E, Bouvard M, Marks I: Exposure therapy, fluvoxamine, or combination treatment in obsessive-compulsive disorder: One-year followup. Psychiatry Res 1993, 49:63-75.
48. Kordon A, Kahl KG, Broocks A, et al.: Clinical outcome in patients with obsessive-compulsive disorder after discontinuation of SRI treatment: Results from a two-year follow-up. Eur Arch Psychiatry Clin Neurosci 2005, 255:48-50.
49. Foa EB, Kozak MJ, Steketee GS, McCarthy PR: Treatment of depressive and obsessive-compulsive symptoms in OCD by imipramine and behaviour therapy. Br J Clin Psychol 1992, 31:279-292.
50. Tolin DF, Maltby N, Diefenbach GJ, Hannan SE, Worhunsky P: Cognitive-behavioral therapy for medication nonresponders with obsessive-compulsive disorder: a wait-list-controlled open trial. J Clin Psychiatry 2004, 65:922-931.
51. Franklin ME, Abramowitz JS, Bux DA, et al.: Cognitive-behavioral therapy with and without medication in the treatment of obsessive-compulsive disorder. Professional Psychol Res Pract 2002, 33:162-168.
52. Rachman SJ: Naughty thoughts. Paper Presented at the European Association for Behavioural & Cognitive Therapies Annual Meeting. Manchester, UK; September 2004.
53. Rachman SJ: The Treatment of Obsessions. New York: Oxford University Press, 2003.
54. Freeston MH, Ladouceur R, Gagnon F, Thibodeau N: Cognitive - behavioral treatment of obsessive thoughts: A controlled study. J Consult Clin Psychol 1997, 65:405-413.